Rhoen-Klinikum AG(RHKJF)

Research Snapshot

Rhoen-Klinikum AG (RHKJF) is a Healthcare stock with a market cap of $830.00M and listed on OTC. The stock last traded around $15.30 and up 0.0% across the available one-year price window (Jun 20, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +21.3%, EPS growth of -23.9%, a dividend yield of 0.8%. What stands out right now is revenue +21.3%, EPS -23.9%, free cash flow -160.5% with operating margin 2.4% and ROIC 2.2%. The dividend is present but secondary, with a yield around 0.8%. Valuation is more restrained than many high-expectation growth names at P/E 24.1 and price/sales 0.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines RHKJF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.